Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-controlled, Triple-blind, Pre-post Interventional Study of Swallowable Cannabigerol Tablets on Sleep Quality in Veterans

NCT05088018 is registered in ClinicalTrials.gov with Chris Emerson as lead sponsor.

NCT NCT05088018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05088018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-controlled, Triple-blind, Pre-post Interventional Study of Swallowable Cannabigerol Tablets on Sleep Quality in Veterans
Lead sponsor
Chris Emerson
Phase
Not applicable
Overall status
Completed
Start date
October 11, 2021
Completion date
May 11, 2022
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sleep